JPRN-UMIN000053014已完成Unknown
A study on the Cholesterol Reduction Effects of Krill Oil Intake - Double-blind, Placebo-Controlled, Randomized, Parallel Group Comparison Trial - A study on the Cholesterol Reduction Effects of Krill Oil Intake
TRIONE CO.,LTD0 个研究点目标入组 80 人开始时间: 2023年12月14日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.have had medical treatment for any disease or have been on any other drugs and Kampo medicines in the past 6 months. 2.have a current or past history of clinically significant acute or chronic diseases requiring acute or chronic treatment in various body systems including cardiovascular, endocrine, immune, respiratory, hepatobiliary, renal and urinary, neuropsychiatric, musculoskeletal, inflammatory, hematologic and tumoral, and gastrointestinal diseases, or systemic infectious diseases. 3.have undergone antipsychotic drug treatment in the past 3 months. 4.Those undergoing diet or exercise therapy under the supervision of a physician. 5.current or past history of serious diseases other than those mentioned in 2. 6.currently taking medicines, quasi-drugs, FOSHU, FFC, health foods, or supplements that may affect weight, blood triglycerides, or cholesterol levels. 7.currently taking drugs or foods other than those mentioned in 6, at least three times a week. However, those who can stop taking them after obtaining consent can participate. 8.AST or ALT levels more than three times the upper limit of the standard at visit 1. 9.serum creatinine levels of 2.0mg/dL or more at visit 1. 10.have a current or past history of drug or food allergies. 11.have a past history of significant hypersensitivity to krill oil components. 12.planning to make major changes to their lifestyle habits during the trial period. 13.planning to travel overseas during the trial period. 14.pregnant, lactating, or wishing to become pregnant during the trial period. 15.shift workers. 16.have a past history of alcohol addiction or drug abuse. 17.heavy drinkers (40g or more of alcohol/day). 18.heavy smokers (more than 21 cigarettes/day). 19.have participated in other clinical trials within one month prior to obtaining consent, are currently participating, or plan to participate during the trial period. 20.Those deemed unsuitable for participation in this study by the principal investigator.
研究者
相似试验
已完成
不适用
Crossover study on blood cholesterol reduction by pregelatinized brown rice ingestedDL cholesterol 120 ~ 159 mg / dL and, BMI 23 ~ 30. Healthy people.JPRN-UMIN000015710Hitachi health management center120
已完成
不适用
Evaluation of cholesterol reduction effect by ingesting concentrated red maltJPRN-UMIN000029727Shiba Palace Clinic30
未知
不适用
Clinical study on anti-atherosclerotic effect of azelnidipine/amlodipine in the hypertensive patients with type 2 diabetesHypertensionJPRN-UMIN000000495Advanced Medicine Study Group in Kyushu Island150
已完成
不适用
Effect of cholesterol lowering on progression of aortic stenosis in patients with mild to moderate aortic stenosisAortic stenosis (AS)Circulatory SystemNonrheumatic aortic valve disordersISRCTN32424163niversity of Ottawa (Canada)264
已完成
不适用
Evaluation of the lipid-lowering effects of the BruMeChol™ dietary supplement in subjects with mild hypercholesterolemiaACTRN12619000170123IRCCS INRCA125